Back to News
Market Impact: 0.3

PJT Crosses Above Average Analyst Target

PJTATROHPPUNFNDAQ
Analyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
PJT Crosses Above Average Analyst Target

Shares of PJT Partners Inc (PJT) have recently traded above the average analyst 12-month target price of $95.50, reaching $96.20, which typically prompts analysts to either upgrade their targets or downgrade on valuation. This development signals investors to reassess the stock for potential further upside or stretched valuation, especially as the average analyst rating has subtly deteriorated from 2.0 to 3.0 over the past three months, marked by a reduction in "Strong Buy" ratings and the introduction of a "Strong Sell" recommendation.

Analysis

PJT Partners Inc. (PJT) shares have recently breached the average analyst 12-month price target of $95.50, trading at $96.20 per share. This technical event creates a pivotal moment for the stock, forcing a re-evaluation of its valuation. While the analyst target range is wide, spanning from $89.00 to $100.00 with a standard deviation of $5.066, the crossing of the consensus average warrants close attention. This price strength is occurring against a backdrop of deteriorating analyst sentiment. Over the past three months, the average analyst rating has weakened from a 2.0 ('Buy') to a 3.0 ('Hold'). This shift was driven by a decrease in 'Strong Buy' ratings from two to one, an increase in 'Hold' ratings from two to three, and the notable emergence of a 'Strong Sell' rating within the last month. The divergence between positive price momentum and weakening, more polarized analyst conviction suggests that while the market is rewarding the stock, underlying expert opinion is growing more cautious.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.10

Ticker Sentiment

ATRO0.00
HPP0.00
NDAQ0.00
PJT0.30
UNF0.00

Key Decisions for Investors

  • Given that the stock has surpassed its average price target while analyst sentiment has simultaneously deteriorated, investors should re-evaluate their thesis to determine if the current valuation is justified or if it is time to consider taking profits.
  • Monitor upcoming analyst reports closely; upward revisions to the $100.00 high target could sustain momentum, but any further downgrades or a shift in 'Hold' ratings could signal a near-term top, especially with the appearance of a new 'Strong Sell' opinion.